Fund Holdings — Pennant Investors, LP

Total Portfolio Value
$366.26M
Total Bought
$62.25M
Total Sold
$63.42M
Net Transaction
-$1.17M
Filing Period:
Securities
▲▼
SharesValue ($K)
Q1 2024
▲▼
Q2 2024
▲▼
Change
▲▼
Q1 2024
▲▼
Q2 2024
▲▼
Weight (%)
▲▼
Change
▲▼
MICRON TECHNOLOGY INC(MU)306,000431,000+125,00036,07456,68915.48%+20,615
VALMONT INDS INC(VMI)040,000+40,000010,9783.00%+10,978
GE VERNOVA INC(GEV)060,000+60,000010,2912.81%+10,291
VERTIV HOLDINGS CO(VRT)0115,000+115,00009,9562.72%+9,956
ECHOSTAR CORP(ECHO)2,153,2092,153,209030,68338,34910.47%+7,665
IRIS ENERGY LTD
ORDINARY SHARES
0470,000+470,00005,3061.45%+5,306
CORE SCIENTIFIC INC NEW(CORZ)0500,000+500,00004,6501.27%+4,650
ALPHABET INC(GOOG)199,000183,000-16,00030,03533,3339.10%+3,298
PERIMETER SOLUTIONS SA(PRM)2,300,0002,300,000017,06618,0094.92%+943
NOVAVAX INC(NVAX)60,30060,30002887630.21%+475
TRAVERE THERAPEUTICS INC(TVTX)055,800+55,80004590.13%+459
NURIX THERAPEUTICS INC(NRIX)56,80056,80008351,1850.32%+350
AGIOS PHARMACEUTICALS INC(AGIO)15,10015,10004426510.18%+210
ERASCA INC(ERAS)166,200166,20003423920.11%+50
REPLIMUNE GROUP INC(REPL)30,50030,50002492750.07%+25
GRAB HOLDINGS LIMITED
*W EXP 99/99/999
80,00080,000016130.00%-3
ALLOVIR INC215,700215,70001631560.04%-7
SERES THERAPEUTICS INC(MCRB)292,300292,30002262120.06%-15
BLUEBIRD BIO INC87,40087,4000112860.02%-26
UNIQURE NV(QURE)48,50048,50002522170.06%-35
ALLAKOS INC186,100186,10002341860.05%-48
RELAY THERAPEUTICS INC(RLAY)42,40042,40003522760.08%-75
ZYMEWORKS INC(ZYME)38,70038,70004073290.09%-78
ARCUS BIOSCIENCES INC(RCUS)23,70023,70004473610.10%-87
ARCUTIS BIOTHERAPEUTICS INC(ARQT)170,900170,90001,6941,5890.43%-104
COHERUS BIOSCIENCES INC(CHRS)168,100168,10004022910.08%-111
AIRSPAN NETWORKS HOLDINGS IN1,047,4730-1,047,4731180—-118
ARCTURUS THERAPEUTICS HLDGS(ARCT)13,10013,10004423190.09%-123
BIOXCEL THERAPEUTICS INC(BTAI)83,90083,90002371070.03%-129
SAGE THERAPEUTICS INC17,50017,50003281900.05%-138
ENANTA PHARMACEUTICALS INC(ENTA)35,10035,10006134550.12%-158
89BIO INC44,50044,50005183560.10%-162
IGM BIOSCIENCES INC64,90064,90006264460.12%-180
COMPASS THERAPEUTICS INC(CMPX)199,000199,00003941990.05%-195
GETAROUND INC1,348,1531,348,15304141890.05%-225
AGENUS INC(AGEN)469,6000-469,6002720—-272
ALLOGENE THERAPEUTICS INC128,400128,40005742990.08%-275
ZENTALIS PHARMACEUTICALS INC(ZNTL)32,40032,40005111330.04%-378
ALTIMMUNE INC(ALT)109,800109,80001,1187300.20%-388
TRAVERE THERAPEUTICS INC55,8000-55,8004300—-430
MACROGENICS INC(MGNX)43,80043,80006451860.05%-459
FATE THERAPEUTICS INC(FATE)146,100146,10001,0724790.13%-593
FIBROGEN INC768,400768,40001,8066860.19%-1,120
THE ODP CORP400,000400,000021,22015,7084.29%-5,512
ANTERO RESOURCES CORP(AR)1,133,000836,000-297,00032,85727,2797.45%-5,578
AMAZON COM INC(AMZN)296,000240,000-56,00053,39246,38012.66%-7,012
TRANSDIGM GROUP INC(TDG)42,00032,371-9,62951,72741,35811.29%-10,370
MICROSOFT CORP(MSFT)112,00080,000-32,00047,12135,7569.76%-11,365
ENOVIS CORPORATION(ENOV)400,0000-400,00024,9800—-24,980
Page 1 of 1
Pennant Investors, LP — 13F Holdings — Q2 2024 | TickerTrail